Crossmark

Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41598-024-84916-w

Published Online: 2025-01-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Dongming

Cao, Donghui

Zhang, Yangyu

Yu, Xinyi

Wu, Yanhua

Jia, Zhifang

Jiang, Jing

Cao, Xueyuan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82373664)

Scientific and Technological Development program of Jilin Province (20240402015GH)
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Received: 31 August 2024

Accepted: 30 December 2024

First Online: 2 January 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below